Candy-Plug技术处理B型及残余A型主动脉夹层假腔结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入6项研究共128例患者(83%男性),评估Candy-Plug技术封闭B型及残余A型主动脉夹层假腔的技术与临床成功。汇总技术成功率96%(95%CI 88-98),临床成功率76%(95%CI 58-88),假腔血栓形成率71%(95%CI 55-83),主动脉重塑率50%(95%CI 33-66)。结论认为CP技术技术成功率高、假腔血栓形成及主动脉重塑率较高,但临床成功率偏低,长期耐久性数据有限,可能需终身严格随访。
要点
- Candy-Plug技术汇总技术成功率96%,临床成功率76%。
- 假腔血栓形成率71%,主动脉重塑率50%。
- 定制装置技术成功率98.5%,医师改良技术92.7%。
核心结论
- CP技术似乎是 promising 的解决方案,技术成功、假腔血栓形成和主动脉重塑率高,但临床成功率趋于较低。
- 鉴于器械长期耐久性数据有限,可能需终身严格随访以监测CP相关并发症。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南系统检索截至2024年11月的文献。
- 初检识别106项研究标题,最终纳入6项合格研究,共128例患者(83%男性)。
- 采用固定或随机效应模型估计汇总技术成功率和临床成功率及相应95%CI。
主要发现
- 汇总技术成功率为96%(95%CI 88-98),汇总临床成功率为76%(95%CI 58-88)。
- 定制制造装置(CMD)技术成功率为98.5%(95%CI 92-99;I2=0%;p=0.78,2项研究),医师改良CP技术(pmCP)为92.7%(95%CI 77-98;I2=0%;p=0.79,4项研究)。
- 总体假腔血栓形成率为71%(95%CI 55-83):CMD为80%(95%CI 57-92;I2=0%;p=0.90,2项研究),pmCP为63%(95%CI 27-88;I2=0%;p=0.99,4项研究)。
- 汇总主动脉重塑率为50%(95%CI 33-66):CMD为63.2%(95%CI 52.7-72.5;I2=69%;p=0.68,2项研究),pmCP为35.9%(95%CI 17-54%;I2=39%;p=0.17,4项研究)。
- CP相关再干预早期发生率为7.1%[CMD 11.5%(95%CI 0.3-8.4;I2=0%;p=0.09,2项研究),pmCP 5.1%(95%CI 1.3-18;I2=0%;p=0.96,4项研究)],晚期为12.8%[CMD 4.5%(95%CI 0.3-39;I2=69%;p=0.68,2项研究),pmCP 4.6%(95%CI 0.9-19;I2=0%;p=0.90,4项研究)]。
关键数值与推荐
- 技术成功汇总值96%(95%CI 88-98),临床成功汇总值76%(95%CI 58-88)。
- CMD技术成功率98.5%(95%CI 92-99),pmCP技术成功率92.7%(95%CI 77-98)。
- 假腔血栓形成率CMD 80%(95%CI 57-92) vs pmCP 63%(95%CI 27-88)。
- 主动脉重塑率CMD 63.2%(95%CI 52.7-72.5) vs pmCP 35.9%(95%CI 17-54%)。
- CP相关再干预早期CMD 11.5%(95%CI 0.3-8.4) vs pmCP 5.1%(95%CI 1.3-18);晚期CMD 4.5%(95%CI 0.3-39) vs pmCP 4.6%(95%CI 0.9-19)。
临床怎么用
- CP技术可用于B型及残余A型主动脉夹层假腔封闭,技术成功率高。
- 医师改良CP技术是可行且有前景的替代技术,具有高初期技术和临床成功率。
- 定制CP装置交付时间因国家和血管外科服务而异,使手术规划困难,尤其对症状性患者或假腔直径快速进展者。
- 鉴于长期耐久性数据有限,可能需终身严格随访以监测CP相关并发症。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We performed a systematic review and meta-analysis to evaluate the technical and clinical success of false lumen occlusion with the Candy-plug (CP) technique in patients with type B and residual type A aortic dissection. MATERIALS AND METHODS: A systematic search of all the literature reported until November 2024 was performed according to the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. The pooled technical and clinical success and corresponding 95% confidence intervals (CIs) were estimated using fixed or random effect methods. RESULTS: A total of 106 study titles were identified by the initial search strategy, of which 6 were considered eligible for inclusion in the meta-analysis. A total of 128 patients (83% male) were identified among the eligible studies. The pooled technical and clinical success rate among the studies were 96% (95% CI, 88-98) and 76% (95% CI, 58-88) respectively. The technical success for custom-made manufacturing device (CMD) was 98.5% (95% CI, 92-99; I2=0%; p=0.78, 2 studies) while for the physician modified CP technique (pmCP) technique was 92.7% (95% CI, 77-98; I2=0%; p=0.79, 4 studies). Overall, false lumen thrombosis rate was 71% (95% CI, 55-83): 80% (95% CI, 57-92; I2=0%; p=0.90, 2 studies) for CMD while for the pmCP technique was 63% (95% CI, 27-88; I2=0%; p=0.99, 4 studies). The pooled aortic remodeling rate was 50% (95% CI, 33-66): 63.2% (95% CI, 52.7-72.5; I2=69%; p=0.68, 2 studies) for CMD, while for the pmCP technique was 35.9% (95% CI, 17-54%; I2=39%; p=0.17, 4 studies). The incidence of CP related reinterventions were 7.1% [11.5% for CMD (95% CI, 0.3-8.4; I2=0%; p=0.09, 2 studies) and 5.1% for pmCP (95% CI, 1.3-18; I2=0%; p=0.96, 4 studies)] and 12.8% [4.5% for CMD (95% CI, 0.3-39; I2=69%; p=0.68, 2 studies), while for the pmCP technique was 4.6% (95% CI, 0.9-19; I2=0%; p=0.90, 4 studies)] in the early and late period. CONCLUSION: CP technique appears to be a promising solution demonstrating high technical success, false lumen thrombosis, and aortic remodeling rate. However, the clinical success rate tends to be lower. Life-long and strict follow-up of these patients may be necessary to monitor CP-related complications, given the limited data on the long-term durability of these devices.Clinical ImpactThis study provides detailed information on a physician-modified candy plug technique in patients with patent False lumen in Type B or residual Type A aortic dissection. As the custom-made candy plug devices have been developed, the delivery time for them varies between countries and vascular surgery services, making the planning of the procedure difficult, especially in symptomatic patients or those with rapid FL diameter progression. The aim of the present study was to collect all available evidence on the fate of the false lumen of the use of custom-made and pmCP technique in TBAD and residual type A aortic dissection.Overall the results suggest that physician modified candy-plug technique is a feasible and promising alternative technique, with high primary technical and clinical success rate.
引用
- Karaolanis GI, Kotopoulos K, D'Amico R, et al. The Fate of False Lumen in Type B and Residual Type A Aortic Dissection Using the Candy-Plug Technique: A Systematic Review and Meta-Analysis. J Endovasc Ther. 2025. PMID: 40521780. doi:10.1177/15266028251344808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。